Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
J Renal Inj Prev
. 2016;5(2): 104-107. doi:
10.15171/jrip.2016.22
PMID:
27471744
PMCID:
PMC4962669
Original Article
A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis
Fatemeh Yaghoubi
1
* , Farrokhleghah Ahmadi
1
, Mahboub Lesanpezeshki
1
, Mitra Mahdavi Mazde
1
Cited by CrossRef: 3
1- Alimohammadi N, Javadian P, Malekpour A, Tahmasebian S. Association of serum fibroblast growth factor 23 with calcium metabolism in patients with end-stage renal disease undergoing hemodialysis.
J Nephropathol
. 2017;6(4):352
[Crossref]
2- Kanda E, Ai M, Okazaki M, Yoshida M, Maeda Y, Shimosawa T. Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho.
PLoS ONE
. 2016;11(11):e0166459
[Crossref]
3- Fauconnier C, Roy T, Gillerot G, Roy C, Pouleur A, Gruson D. FGF23: Clinical usefulness and analytical evolution.
Clinical Biochemistry
. 2019;66:1
[Crossref]